Tsingke Biotech is a leader in synthetic biology, committed to building a world-class gene factory. By integrating AI-driven molecular manufacturing with advanced expertise in gene reading, editing, and writing, the company has established a fully independent R&D ecosystem spanning the entire workflow from raw materials to sequencing.

Within this ecosystem, Tsingke Biotech is advancing three intelligent manufacturing platforms: high-throughput oligonucleotide screening, antibody discovery and production, and microbial strain engineering and screening. 

Leveraging in-house reagents, proprietary synthesizers, and automated systems, these platforms enable scalable, precise, and end-to-end processes from gene design to functional molecule screening, supporting applications across biopharmaceuticals, industrial biotechnology, agriculture, food, and environmental science.

Headquartered in Beijing, Tsingke Biotech operates a 12,000+㎡ R&D center and cleanroom facilities, holds over 300 patents, and maintains certified quality, environmental, and occupational health systems. Its production environment is ISO 13485-certified, and the company holds Class II and III medical device licenses.

Guided by the values of Quality, Innovation, Dedication, and mutually beneficial collaboration, Tsingke Biotech applies innovative approaches to advance biotechnology and drive industry-wide progress.

Tsingke Biotech

Org chart

Teams

Offices